This week, more people are getting vaccinated against the new coronavirus. Following the priority vaccination of frontline health care workers, many states have begun vaccinating elderly people living in long-term care centers. Several U.S. military bases overseas have also received the vaccine. On the other hand, three new vaccines are in the final stages of testing.
With a cheer, Shirley, a retired teacher, received the vaccine at the Edgar Benjamin Health Care Center in Boston.
The reporter asked, “How does it feel?”
Shirley, a retired teacher, said, “It’s good. I’m glad I can start dealing with this virus that’s going around.”
Following the priority vaccination of front-line health care workers, the vaccination of elderly people living in long-term care centers has also been underway for a week. Tony Francis, director of the Edgar Benjamin Health Care Center, which was founded and is operated by African-Americans, expressed satisfaction with the progress so far.
The residents here are happy,” said Tony Francis, CEO of Edgar Benjamin Health Care Center. It’s amazing that 95 percent of our residents have agreed to be vaccinated. People tell me that’s a remarkable achievement, because most centers only have 25 to 30 percent, up to 40 percent.”
Despite the introduction of the new crown vaccine, many people still have doubts about its safety. According to one survey, only 49 percent of African-Americans expressed interest in getting the new crown vaccine, compared with 63 percent of white Americans who would be willing to get the vaccine.
On the other hand, vaccination efforts are also underway at U.S. military bases overseas. On Monday, the first vaccinations continued at the U.S. Air Force in Yokota, Japan, and the U.S. Army in Korea has distributed the Modena New Coronavirus vaccine to its three disposal centers.
Novavax Pharmaceuticals has announced that its Neovirus vaccine is in the final stages of large-scale testing. Novavax Pharmaceuticals previously delayed the large-scale trial twice because of issues related to the production process for expanding production. The trial will be conducted at 115 sites in the United States and Mexico and will involve 30,000 volunteers.
Two-thirds of the volunteers will be injected twice 21 days apart, while the rest will be given a placebo. Pfizer and Modena have already received emergency use authorizations for their new coronavirus vaccines in the U.S., and Phase III clinical trials of Johnson and AstraZeneca vaccines are already underway.
Recent Comments